Cutaneous and mucocutaneous leishmaniasis

Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and m...

Full description

Saved in:
Bibliographic Details
Published inInfectious disease clinics of North America Vol. 26; no. 2; p. 293
Main Authors Goto, Hiro, Lauletta Lindoso, José Angelo
Format Journal Article
LanguageEnglish
Published United States 01.06.2012
Subjects
Antiprotozoal Agents - therapeutic use
Drug Therapy, Combination
HIV Infections - complications
Humans
Leishmania - growth & development
Leishmania - pathogenicity
Leishmaniasis, Cutaneous - diagnosis
Leishmaniasis, Cutaneous - pathology
Leishmaniasis, Cutaneous - therapy
Leishmaniasis, Cutaneous - transmission
Leishmaniasis, Mucocutaneous - diagnosis
Leishmaniasis, Mucocutaneous - pathology
Leishmaniasis, Mucocutaneous - therapy
Leishmaniasis, Mucocutaneous - transmission
Mass Screening - methods
Travel
Online AccessGet more information

Cover

More Information
Summary:Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated, or diffuse in distribution and may differ in Old and New World leishmaniases. Diagnosis and treatment vary according to the clinical manifestations, geographic area, and Leishmania species involved. This article highlights the diversity and complexity of tegumentary leishmaniases, which are worsened by human immunodeficiency virus/Leishmania coinfection.
ISSN:1557-9824
DOI:10.1016/j.idc.2012.03.001